Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$25.65 -0.02 (-0.08%)

As of 07/24/2026 04:10 PM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Scholar Rock. The top 22 THNR holdings ordered by weight make up 100.01% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 22 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$48.76 +1.2%	9.99%	8,881
2	LLY Eli Lilly and Company	$1,196.18 +0.9%	9.10%	337
3	SRRK Scholar Rock	$47.67 -3.7%	5.84%	4,531
4	Innovent Biologics, Inc.	N/A	5.59%	21,500
5	HIMS Hims & Hers Health	$28.10 -14.2%	5.48%	7,013
6	VKTX Viking Therapeutics	$34.79 -1.7%	5.43%	6,142
7	CSPC Pharmaceutical Group Limited	N/A	5.17%	220,000
8	REGN Regeneron Pharmaceuticals	$656.01 +0.6%	5.15%	341
9	ABBV AbbVie	$259.10 +0.8%	5.08%	901
10	AMGN Amgen	$376.04 +1.2%	4.87%	589
11	Roche Holding AG	N/A	4.86%	513
12	ARWR Arrowhead Pharmaceuticals	$85.60 -1.4%	4.73%	2,722
13	MRK Merck & Co., Inc.	$131.06 +0.4%	4.71%	1,677
14	Chugai Pharmaceutical Co., Ltd.	N/A	4.46%	4,300
15	AstraZeneca PLC	N/A	4.46%	1,143
16	PFE Pfizer	$24.53 -1.9%	4.37%	7,957
17	Zealand Pharma A/S	N/A	3.36%	3,434
18	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.30%	13,400
19	KLRA Kailera Therapeutics	$17.69 +1.7%	2.29%	4,864
20	Hanmi Pharm. Co., Ltd.	N/A	2.01%	341
21	Short-Term Investment Trust - Invesco Government & Agency Portfolio	N/A	0.54%	23,636
22	OTHER ASSETS AND LIABILITIES	N/A	0.22%	168,838,657

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 135.2%, followed by Cayman Islands at 11.1%.

United States
100.0%
Cayman Islands
11.1%
Hong Kong
10.6%
United Kingdom
8.8%
Japan
8.4%
Denmark
7.1%
Korea, Republic of
4.1%

THNR Currency Exposure

THNR is predominantly exposed to USD at 148.9%, followed by HKD at 26.0%.

USD
100.0%
HKD
26.0%
JPY
8.4%
DKK
7.1%
KRW
4.1%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 179.0%.

Health Care
100.0%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 168.5%, followed by Health Care Providers & Services at 10.5%.

Biotechnology
100.0%
Health Care Providers & Services
10.5%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 168.5%, followed by Health Care Services at 10.5%.

Biotechnology
100.0%
Health Care Services
10.5%

THNR Coupon Exposure

THNR's largest coupon exposure is 2-4 at 1.2%.

2-4
1.2%

THNR Maturity Exposure

THNR's largest maturity exposure is 5-10 at 1.2%.

5-10
1.2%

Related Companies and Tools

Related Companies

This page (NYSEARCA:THNR) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List